Literature DB >> 11815711

The role of vascular endothelial growth factor in angiogenesis.

N Ferrara1, H P Gerber.   

Abstract

Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen and an angiogenic inducer as well as a mediator of vascular permeability. The biological effects of VEGF are mediated by two tyrosine kinase receptors, Flt-1 (VEGFr-1) and KDR (VEGFR-2). VEGF is essential for developmental angiogenesis and is also required for female reproductive functions and endochondral bone formation. Substantial evidence also implicates VEGF in tumors and intraocular neovascular syndromes. Currently, several clinical trials are ongoing to test the hypothesis that inhibition of VEGF activity may be beneficial for these conditions. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11815711     DOI: 10.1159/000046610

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  104 in total

1.  Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis.

Authors:  Jiawei He; Martin L Decaris; J Kent Leach
Journal:  Tissue Eng Part A       Date:  2012-06-07       Impact factor: 3.845

2.  Non-invasive Monitoring of Angiogenesis in Cardiology.

Authors:  Martin Rodriguez-Porcel
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-02

Review 3.  Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence.

Authors:  Eleftherios Spartalis; Periklis Tomos; Demetrios Moris; Antonios Athanasiou; Charalampos Markakis; Michael D Spartalis; Theodore Troupis; Dimitrios Dimitroulis; Despina Perrea
Journal:  World J Cardiol       Date:  2015-10-26

4.  Efficacy and safety of ranibizumab for wet age-related macular degeneration in Chinese patients.

Authors:  Hui-Jun Qi; Xiao-Xin Li; Jun-Yan Zhang; Ming-Wei Zhao
Journal:  Int J Ophthalmol       Date:  2017-01-18       Impact factor: 1.779

5.  Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes the vascular endothelial growth factor-stimulated MAPKs and downstream effectors AP-1 and CREB in mouse mesangial cells.

Authors:  Satyabha Tripathi; Kailash N Pandey
Journal:  Mol Cell Biochem       Date:  2012-05-19       Impact factor: 3.396

Review 6.  Targeted therapies for gastric cancer: current status.

Authors:  Jaclyn Yoong; Michael Michael; Trevor Leong
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

7.  Microvessel density is a prognostic marker of human gastric cancer.

Authors:  Hong-Chuan Zhao; Rong Qin; Xiao-Xin Chen; Xia Sheng; Ji-Feng Wu; Dao-Bin Wang; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

8.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

9.  Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).

Authors:  Dimitri T Azar
Journal:  Trans Am Ophthalmol Soc       Date:  2006

10.  Anti-angiogenesis approach to genitourinary cancer treatment.

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Update Cancer Ther       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.